The mechanism linking low PPARδ1 and ALOX5 to MYCN amplification status in neuroblastoma needs to be investigated, and the study raises questions over the potential role of PPARδ1 in promoting cell survival signalling in neuroblastoma (Figure 7). Here, ALOX5 is linked to neuroblastoma.